Post

Tetra Bio-Pharma reports results from trial of ARDS-003 and Favipiravir

Onternabez plays a key role in mitigating the inflammatory response in various inflammatory condition targets.

Alzheimer’s disease drug development: three major questions for 2023

After a chaotic 2022 that saw both drug development successes and failures, the Alzheimer’s disease field faces questions over upcoming data and new therapeutic approaches.

Human Immunodeficiency Virus (HIV) Infections (AIDS) accounts for 6.3% share of global Infectious Disease clinical trial activity in 2021

Medidata unveils new app to accelerate start up of trial

The app is integrated with the Medidata Platform, including the Rave EDC, to offer a self-sustaining ecosystem.

US FDA grants clearance to commence trials of Sorrento’s mRNA vaccine

The microneedle system, along with an mRNA vaccine candidate, showed enhanced humoral immunity in animal models.

BioAge Labs reports positive data from muscle atrophy treatment trial

Findings showed that BGE-105 resulted in statistically significant improvements in muscle size, quality, and protein synthesis.

Longboard reports positive data from Phase I LP352 clinical study

The trial findings showed that LP352 exhibited a strong correlation between plasma and CSF PK concentration.

Mirati reports initial data from lung cancer trials

Grade 1-2, Grade 3, and Grade 4 treatment-related adverse events were reported in the trial.

Novartis’ Phase III prostate cancer therapy trial meets primary endpoint

Assessing overall survival, which is the crucial secondary endpoint of the trial, is progressing.

Managing drug shortages: Getting medicines to patients in need

Patients around the world are experiencing drug shortages, with production still recovering from the disruption caused by Covid-19, the war in Ukraine, and rising energy costs. Tanner Pharma is tackling these issues head-on, managing disruptions and ensuring that a range of treatments reach patients wherever they are.